Pelthos Therapeutics Inc. Common Stock, Capital Shares Reserved for Future Issuance
Pelthos Therapeutics Inc. (PTHS) had Common Stock, Capital Shares Reserved for Future Issuance of 354.50 thousand shares as of 2026-03-31, per its 10-Q/A filed 2026-08-13.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-13
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 354.50K shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 354.50K shares.
- 2025-04-16: Common Stock, Capital Shares Reserved for Future Issuance 2.40M shares.
- 2024-06-12: Common Stock, Capital Shares Reserved for Future Issuance 194.44K shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2026-03-31 | 354.50K shares 10-Q/A · filed 2026-08-13 |
| 2025-12-31 | 354.50K shares 10-K · filed 2026-03-19 |
| 2025-04-16 | 2.40M shares 10-Q/A · filed 2026-08-13 |
| 2024-06-12 | 194.44K shares 10-Q/A · filed 2026-08-13 |
| 2024-06-11 | 44.44K shares 10-Q/A · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |